Mabpharm Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange HealthCare May 20, 2019 Offer Price Set Between HK$1.50 to HK$1.95 per Share, To Raise Gross Proceeds Up to HK$1,528 Million A Leading Biopharmaceutical…
